key: cord-0263668-fdrvjs5s
authors: HARAPAS, C. R.; ROBINSON, K.; LAY, K.; WONG, J.; RAAS-ROTHSCHILD, A.; LAOHAMONTHONKUL, P.; BOISSON, B.; DRUTMAN, S. B.; GORRELL, M.; BONNER, D.; YU, C.-H.; DAVIDSON, S.; KAYSERILI, H.; HATIPOGLU, N.; CASANOVA, J. L.; BERNSTEIN, J. A.; Zhong, F. L.; Masters, S. L.; REVERSADE, B.
title: DPP9 deficiency: an inflammasomopathy which can be rescued by lowering NLRP1/IL-1 signaling
date: 2021-02-03
journal: nan
DOI: 10.1101/2021.01.31.21250067
sha: c57e322b5b520eefcc8d47efbd6cac54d50ad64c
doc_id: 263668
cord_uid: fdrvjs5s

Dipeptidyl peptidase 9 (DPP9) is a direct inhibitor of NLRP1, but how it impacts inflammasome regulation in vivo is not yet established. Here, we report two families with immune-associated defects, skin pigmentation abnormalities and neurological deficits that segregate with biallelic DPP9 rare variants. Using patient-derived primary cells and biochemical assays, these variants are shown to behave as hypomorphic or loss-of-function alleles that fail to repress NLRP1. Remarkably, the removal in mice, of a single copy of either Nlrp1a/b/c, Asc, Gsdmd, Il-1r, but not Il-18, was sufficient to rescue the lethality of Dpp9 mutant neonates. These experiments suggest that the deleterious consequences of DPP9 loss are mainly driven by the aberrant activation of the canonical NLRP1 inflammasome and IL-1{beta} signaling. Collectively, our results delineate a Mendelian disorder of DPP9 deficiency driven by increased NLRP1 activity as demonstrated in patient cells and in a mouse model of the disease.

The human NLRP1 inflammasome is a multi-protein complex that is triggered by viral infections ( 1 , 2 ) or danger-associated signals ( 3 ) , resulting in the release of proinflammatory cytokines, including IL-1 family members, IL-1β and IL-18 ( 4 ) . Dysregulation of the human NLRP1 inflammasome is associated with a range of inflammatory Mendelian diseases such as Multiple Self-healing Palmoplantar Carcinoma (MSPC, MIM615225) ( 5 ) , Juvenile Recurrent Respiratory Papillomatosis (JRRP, 618803MIM) ( 6 ) , and Autoinflammation with Arthritis and Dyskeratosis (AIADK, MIM617388) ( 7 ) . In the absence of any cognate triggers, inflammasome sensors in the family of Nod-like receptors (NLRs) are maintained in an inactive state by a number of regulatory proteins. For example, NLRP1 is bound to, and repressed by, the enzymatic activity and scaffolding function of dipeptidyl peptidase 9 (DPP9) and DPP8 ( 7 , 8 ) . The role of DPP9 as a negative regulator of human or mouse NLRP1 has been established through pharmacological inhibition of DPP9 and inactivation of DPP9 in cell lines in vitro, but its function has not been documented in vivo.

As part of a cohort of patients with inborn errors of immunity, we studied a child (F2: II. 3) with signs of susceptibility to infections consisting of recurrent facial HSV lesions and airway inflammation, including chronic intermittent asthma and primary pulmonary tuberculosis. Exome sequencing disclosed a germline homozygous stop-gained mutation (c.2551C>T; p.Q851*) in DPP9 ( MIM608258 ) (Fig. 1, A, B and E) which was heterozygous in the parents. A second child (F1: II.1) was identified with help of the GeneMatcher ( 9 ) database and carried compound heterozygous DPP9 variants with a paternal missense mutation (c.449G>A, p.G167S) and a maternal early truncating mutation (c.641C>G; p.S214*) (Fig. 1 , A to C) . Both children shared a triad of symptoms summarized in Table 1 which partially overlapped with NLRP1 gain-of-function mutations causing AIADK ( 7 ) . This consisted of a general failure to thrive, skin manifestations and blood anomalies, which in the case of F1: II.1 required hematopoietic stem cell transplant. The stop-gain mutations found in the two probands are expected to completely abolish the enzymatic activity of DPP9, as its catalytic domain is situated at the C-terminus. The missense mutation p.(G167S) found in proband F1: II.1 affects a residue in a flexible loop that is located at the periphery of the DPP9 substrate binding site (Fig. 1D) . Thus, the DPP9 G167S mutation is predicted to diminish the substrate binding and/or catalytic efficiency. To date, no homozygous damaging variants have been reported for DPP9 which according to genomAD is significantly averse to loss-of-function mutations ( 10 ) .

To investigate the impact of the DPP9 variants on mRNA expression and enzymatic function, primary skin cells were isolated from affected patients of both families ( Fig. 2A ). When compared with control primary fibroblasts, and those derived from the heterozygous parents of family 2 (F2: I.3 and I.4), a significant decrease in DPP9 protein was found in the proband's (F1: II.1) fibroblasts. This was consistent with one allele not encoding the full-length protein due to an early stop mutation p.S214* ( Fig. 2A, lanes 1 and 2) . Notably, we could not observe any endogenous DPP9 protein in the proband of family 2 (F2: II.3), indicating that the stop-gain mutant (p.Q851*) was degraded via the nonsense-mediated decay pathway ( Fig. 2A, lanes 1 and 5) . Thus, the p.Q851* DPP9 variant probably yields a loss-of-expression, resulting in a protein-null allele. We next sought to assess the enzymatic activity of the DPP9 G167S variant towards a model substrate Gly-Pro-AMC ( Fig. 2B and fig.   S1A ). The p.G167S mutation was found to reduce the enzymatic activity to~15% of that of wild-type DPP9.

Given that DPP9 has been identified as a specific interacting partner and inhibitor of human and mouse NLRP1 ( 7 , 8 ) , we measured the ability of DPP9 WT , catalytically-dead DPP9 S759A or the patient DPP9 G167S mutant to repress NLRP1 when re-expressed in DPP8/DPP9 double KO 293T-ASC-GFP reporter cells ( Fig. 2C and fig. S1 , B and C). Exogenous DPP9 WT repressed NLRP1-dependent ASC-GFP speck formation. In contrast, both DPP9 S759A and DPP9 G167S were less effective in inhibiting ASC speck formation. Taken together, these experiments suggest that these DPP9 patient variants are less able to maintain NLRP1 in the inactive state.

We and others have demonstrated that NLRP1 is the most prominent inflammasome sensor in human keratinocytes and that these cells readily undergo pyroptotic cell death in response to NLRP1 activation ( 5 , 11 ) . Using primary keratinocytes isolated from family 2 and the Luminex platform, we found that the cytokine and chemokine profile of the proband differed from those of his heterozygous parents ( fig. S1D ). We demonstrated that the proband keratinocytes, as do keratinocytes from patients with gain-of-function NLRP1 mutations ( 5 ) , spontaneously secreted active IL-1β and IL-18 into the media without any exogenous stimulus. Despite measurable IL-1 release visualised by ELISA and western blot (Fig. 2, D and E respectively), the patient's keratinocytes were viable in culture and could be serially cultured (fig. S1E) for at least 4 passages. This cytokine release was also accompanied by 5 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted February 3, 2021. ; https://doi.org/10.1101/2021.01.31.21250067 doi: medRxiv preprint ASC oligomerization, as demonstrated using a DSS crosslinking assay, and GSDMD cleavage (Fig. 2E ). These data are consistent with a small fraction of the cells undergoing spontaneous inflammasome activation, without overt pyroptosis. A similar phenomenon has been documented in murine macrophages ( 12 ) .

To dissect the pathogenicity of the loss of DPP9 in vivo, we took advantage of the DPP9 mutant mouse line which carries the catalytic-dead DPP9 p.S729A mutation. Homozygous Dpp9 S729A/S729A knock-in mice die within 24 hours of birth ( 13 , 14 ) . Based on our results obtained in patient-derived primary cells, we examined whether this lethality might be associated with overactivation of the NLRP1 inflammasome. Indeed, homozygous loss of all perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in 3I and fig. S3, A and B) . While histological analysis of other organs and automated blood cell analysis showed no overt differences between genotypes ( fig. S3 , C to F). Overall, these results suggest inflammasome-independent roles of DPP9 relating to stature and lung inflammation, which is consistent with the broad range of processes regulated by DPP9.

Decreased stature and lung inflammation were also recorded in DPP9-deficient patients (Table 1) . Notably, two GWAS studies have implicated germline DPP9 variants in the development of pulmonary fibrosis ( 18 , 19 ) and severe COVID19 pathology ( 20 ) .

To further dissect the contribution of downstream components of the NLRP1 signalling axis, we next crossed Dpp9 S729A/S729A mice with strains deficient for effectors of the NLRP1 inflammasome. Both heterozygous and homozygous loss of Asc, Gsdmd and Il-1r rescued Dpp9 S729A/S729A neonatal lethality to a similar extent as Nlrp1 deficiency (Fig. 3J) .

Interestingly, the biallelic loss of Il-18 did not rescue DPP9 loss of function (Fig. 3J) suggesting that Il-1 may be the main driver of the disease. Rescued mice exhibited a similar phenotype to Dpp9 S729A/S729A Nlrp1 -/mice, appearing healthy yet runted. For example, Dpp9 S729A/S729A Gsdmd -/mice did not gain weight at the same rate as controls, and developed the same immune cell infiltrate in their lungs as Dpp9 S729A/S729A Nlrp1 -/mice at 6 months of age, despite normal blood cell counts ( fig. S4 ). The number of rescued Dpp9 S729A/S729A mice that survived to weaning age fell significantly below Mendelian ratios (Fig. 3J) . However, these numbers might be confounded by potential cannibalisation of the runted pups. Overall it is clear that the deletion of a single allele of either Asc , Gsdmd or Il-1r is sufficient to protect Dpp9 S729A/S729A mice. These results raise the possibility that even partial inhibition of the NLRP1-inflammasome pathway, with anti-IL-1β antibodies for example, would provide some therapeutic benefit for DPP9 deficient patients. In further support of this, anti-IL-1β therapy was partially successful in a patient harbouring a germline NLRP1 p.P1214R mutation which abrogated binding and therefore inhibition by DPP9 ( 21 ) .

In summary, we have identified two unrelated families with autosomal recessive DPP9 deficiency, which is characterised by immune-associated defects, dermatological anomalies and neurological deficits. This Mendelian disease bears some degree of resemblance with auto-immune disorders caused by NLRP1 activating mutations. In particular the AIADK-causing NLRP1 p.P1214R mutation which entirely abrogates DPP9 binding and inhibition of NLRP1, is expected to yield comparable phenotypes ( 7 ) . Both diseases appear to 7 All rights reserved. No reuse allowed without permission.

perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in Data and materials availability: All data is available in the main text or the supplementary materials.

Figures S1-S4

13 All rights reserved. No reuse allowed without permission.

perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in

The copyright holder for this this version posted February 3, 2021. ; https://doi.org/10.1101/2021.01.31.21250067 doi: medRxiv preprint 14 All rights reserved. No reuse allowed without permission.

perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in 16 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in Error bars represent mean ±SEM.

Statistical significance for weight data was determined by a paired t-test. Statistical test for the survival curve was determined by a Mantel-Cox test.

18 All rights reserved. No reuse allowed without permission.

perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in

The copyright holder for this this version posted February 3, 2021. ; Table 1 . Syndrome caused by biallelic Loss-of-Function DPP9 mutations n.d., not determined; +, affirmative; -, negative; BM, bone marrow

Enteroviral 3C protease activates the human NLRP1 inflammasome in airway epithelia

Human NLRP1 is a sensor for double-stranded RNA

Genome Editing of Human Primary Keratinocytes by CRISPR/Cas9 Reveals an Essential Role of the NLRP1 Inflammasome in UVB Sensing

Inflammasomes: mechanism of assembly, regulation and signalling

Germline NLRP1 Mutations Cause Skin Inflammatory and Cancer Susceptibility Syndromes via Inflammasome Activation

Homozygous NLRP1 gain-of-function mutation in siblings with a syndromic form of recurrent respiratory papillomatosis

Human DPP9 represses NLRP1 inflammasome and protects against autoinflammatory diseases via both peptidase activity and FIIND domain binding

DPP8 and DPP9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis

GeneMatcher: a matching tool for connecting investigators with an interest in the same gene

Expression of inflammasome proteins and inflammasome activation occurs in human, but not in murine keratinocytes

The Pore-Forming Protein Gasdermin D Regulates Interleukin-1 Secretion from Living Macrophages

Targeted inactivation of dipeptidyl peptidase 9 enzymatic activity causes mouse neonate lethality

DPP9 enzyme activity controls survival of mouse migratory tongue muscle progenitors and its absence leads to neonatal lethality due to suckling defect

Rolink, I. Ksiazek, DPP9 enzymatic activity in hematopoietic cells is dispensable for mouse hematopoiesis

Haemopedia RNA-seq: a database of gene expression during haematopoiesis in mice and humans

Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis

Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis

GenOMICC Investigators, ISARICC Investigators, COVID-19 Human Genetics Initiative

Genetic mechanisms of critical illness in Covid-19

A new autoinflammatory and autoimmune syndrome associated with NLRP1 mutations: NAIAD (NLRP1-associated autoinflammation with arthritis and dyskeratosis)

DPP9's Enzymatic Activity and Not Its Binding to CARD8 Inhibits Inflammasome Activation

A Chemical Strategy for Protease Substrate Profiling

DPP8/9 inhibitors activate the CARD8 inflammasome in resting lymphocytes

Molecular findings among patients referred for clinical whole-exome sequencing

Clinical whole-exome sequencing for the diagnosis of mendelian disorders

Fast and accurate long-read alignment with Burrows-Wheeler transform

The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data

Genome Project Data Processing Subgroup, The Sequence Alignment/Map format and SAMtools

A method and server for predicting damaging missense mutations

A general framework for estimating the relative pathogenicity of human genetic variants

Predicting deleterious amino acid substitutions

Blacklisting variants common in private cohorts but not in public databases optimizes human exome analysis

The mutation significance cutoff: gene-level thresholds for variant predictions

NLRP1 inflammasome activation induces pyroptosis of hematopoietic progenitor cells

Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling

Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice

Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf

Defective NK cell activity and Th1 response in IL-18-deficient mice

We are grateful to all members of the Masters, Zhong and Reversade laboratories for support. We thank Prof. Anthony Oro (Stanford University) for generous help in fibroblast derivation from family 1. We thank E. Kravets for study coordination and M.W.Allain for data collection (Stanford University). We thank S. Russo for outstanding animal husbandry. 

HPO Terms